Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

35.88
Delayed Data
As of Apr 21
 -0.52 / -1.43%
Today’s Change
30.89
Today|||52-Week Range
57.44
+0.06%
Year-to-Date

Today’s Trading

Previous close36.40
Today’s open36.19
Day’s range35.77 - 36.29
Volume1,163,500
Average volume (3 months)2,420,282
Market cap$70.3B
Dividend yield3.74%
Data as of 4:02pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.80%
Revenue growth (last year)+3.81%
P/E ratio2.4
Price/Sales5.48
Price/Book13.99

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.45-1.02%
AZNAstraZeneca-0.14-0.47%
AGNAllergan-1.59-0.67%
BMYBristol-Myers Squibb+0.04+0.07%
Data as of 4:02pm ET, 04/21/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.52
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts


Search for Jobs